You searched for oral corticosteroids

CHEST 2022

Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma

October 19, 2022

Post hoc analysis of the VENTURE/TRAVERSE trials assessed dupilumab efficacy in patients with severe asthma requiring varying levels of oral corticosteroids at baseline.

ACAAI 2022

Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma

November 21, 2022

The researchers conducted a retrospective cohort study using claims data from the Optum Research Database for 538 patients at least 6 years of age who initiated mepolizumab treatment for asthma between January 2016 and December 2019.

ACAAI 2022

Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab

November 16, 2022

Investigators assessed the annualized asthma exacerbation rate (AAER) and the annualized rate of asthma exacerbations requiring hospitalization over 52 weeks.

CHEST 2022

ICS-LABA Proved Effective in Treating Sjogren Syndrome With Bronchiolitis

October 18, 2022

Investigators explored the value of treating patients with bronchiolitis in primary Sjogren’s Syndrome using inhaled corticosteroids and long-acting beta agonists.

CHEST 2022

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

October 17, 2022

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

CHEST 2022

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

October 17, 2022

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

News

Treatment Needs Often Unmet for Generalized Pustular Psoriasis

August 15, 2022

Patients with flares more likely to have inpatient, emergency department visits

AAAAI 2022

Escalation to Biologics in Asthma: The Role of Suboptimal Treatment Adherence

February 25, 2022

To what extent are patients with uncontrolled asthma switched to biologics due to poor treatment adherence vs lack of maintenance therapy efficacy?

News

Tacrolimus May Be an Alternative for First-Line Lupus Nephritis Therapy

April 4, 2022

In a study, the calcineurin inhibitor tacrolimus proved to be noninferior to intravenous cyclophosphamide.

AAAAI 2022

Atopy Status of Patients With Asthma and Exacerbation Rates Post COVID-19

February 25, 2022

Does the allergic status of patients with asthma affect asthma exacerbation rates and outcomes following COVID-19?

Active Filters

Your search for oral corticosteroids returned 13 results

Sort Results:

Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma

Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma

Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab

ICS-LABA Proved Effective in Treating Sjogren Syndrome With Bronchiolitis

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

Treatment Needs Often Unmet for Generalized Pustular Psoriasis

Escalation to Biologics in Asthma: The Role of Suboptimal Treatment Adherence

Tacrolimus May Be an Alternative for First-Line Lupus Nephritis Therapy

Atopy Status of Patients With Asthma and Exacerbation Rates Post COVID-19